Associate Professor I at the Department of Pathology and Legal Medicine, Faculty of Medicine of Ribeirão Preto, University of São Paulo (FMRP/USP), under a full-time dedication scheme. Graduated in Medicine from the Faculty of Medicine of Botucatu, São Paulo State University (FMB/UNESP) in 2005, and board-certified pathologist through the medical residency program at FMB/UNESP in 2009. Completed a PhD in Pathology through the FMB/UNESP Graduate Program in Pathology in 2012, including a Sandwich Doctorate at the University of Graz, Austria, in 2011, and a postdoctoral fellowship at the Department of Pathology, Faculty of Medicine, University of São Paulo (FM/USP) in 2017. Served as Director of the Biobank of HC-FMB/UNESP (20122016), Medical Coordinator of the Experimental Pathology Laboratory (UNIPEX-FMB/UNESP) (20122016), Director of the Multiuser Molecular Pathology Laboratory of the Department of Pathology and Legal Medicine (20172020), Vice-Director of the Center for Genomic Medicine at HC-FMRP/USP (20202021), Preceptor of the Pathology Medical Residency Program of the Pathology Service (SERPAT)/HC-FMRP/USP (20192021), Vice-Coordinator of SERPAT/HC-FMRP/USP (20202023), and Director of the Regional Death Verification Service (SVO-R) (20202023) and Interior Death Verification Service (20222023). Currently, he is an alternate member of the Congregation of FMRP/USP (2023present) and Coordinator of the PneumoPato program and its channel (https://www.youtube.com/c/PneumoPato). His research focuses on pulmonary pathology, including interstitial and vascular lung diseases, molecular pathology, digital pathology, and the biology of lung tumors. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Patients with fibrosing interstitial lung disease (ILD), such as hypersensitivity pneumonitis, highly prevalent in Brazil, may develop acute exacerbations, despite an optimal treatment established, thus promoting a progressive phenotype of high morbidity and mortality in one third of them. Objectives: to unravel the pathophysiology of progressive fibrosing ILDs by validating biomarkers of…
Fibrosing interstitial pneumonitis (FIP) can be defined as an attempt to repair the injured lung tissue, with some or extensive extracellular matrix deposition, causing lung parenchyma disarrangement and septal thickening. The regulatory mechanisms involved in fibrogenesis are complex and with several molecules. FIP can be the common end result to many different lung diseases (for instanc…
Interstitial lung diseases (ILDs) represents a broad and diverse spectrum group of disorders that cause variable degrees of interstitial inflammation and scarring, which may ultimately promote dramatic remodeling of the underlying pulmonary parenchyma architecture. Classification of ILD may be a challenging problem and although multidisciplinary discussions (MDD) by clinicians, radiologis…
(Only some records are available in English at this moment)
Macrophages are immune system cells that play several crucial roles in maintaining the body's homeostasis, including phagocytosis, antigen presentation, cytokine release, and initiation of the inflammatory response. Among various antigens, particulate matter (PM) present in the air is notable. With increasing urbanization and industrial production, air pollution and the inhalation of thes…
Patients with fibrosing interstitial lung disease (ILD), such as hypersensitivity pneumonitis, highly prevalent in Brazil, may develop acute exacerbations, despite an optimal treatment established, thus promoting a progressive phenotype of high morbidity and mortality in one third of them. To unravel the pathophysiology of progressive fibrosing ILDs by validating biomarkers of its progres…
Fibrosing interstitial pneumonitis (FIP) can be defined as an attempt to repair the injured lung tissue, with some or extensive extracellular matrix deposition, causing lung parenchyma disarrangement and septal thickening. The regulatory mechanisms involved in fibrogenesis are complex and with several molecules. FIP can be the common end result to many different lung diseases (for instanc…
Background: Patients with fibrosing interstitial lung disease (ILD), such as hypersensitivity pneumonitis, highly prevalent in Brazil, may develop acute exacerbations, despite an optimal treatment established, thus promoting a progressive phenotype of high morbidity and mortality in one third of them. Objectives: to unravel the pathophysiology of progressive fibrosing ILDs by validating b…
Hypersensitivity pneumonitis has been highlighted as one of the main causes of interstitial lung disease in Brazil, being mediated by types III and IV hypersensitivity reactions in response to the inhalation of various environmental agents, with the formation of cellular bronchiolitis and/or granulomas and, often progressing to pulmonary fibrosis. Regardless of the reactions that mediate …
Interstitial lung diseases (ILDs) are a large heterogenic group of disorders that cause scarring with architectural distortion of pulmonary interstitium. Nonspecific clinical, radiological and pathological findings could not allow an accurate diagnosis despite the multidisciplinary discussion (MDD) with pneumologists, thoracic radiologist and pulmonary pathologist. The bronchiolocentric i…
(Only some records are available in English at this moment)
Fibrosing interstitial pneumonitis (FIP) can be defined as an attempt to repair injured lung tissue, with some extensive deposition of extracellular matrix, leading to disarrangement of the lung parenchyma and septal thickening. The regulatory mechanisms involved in fibrogenesis are complex and involve a number of molecules. FIP can be the common end result of many distinct lung diseases …
| 1 / 1 | Ongoing grants |
| 6 / 6 | Completed research grants |
| 3 / 3 | Ongoing scholarships in Brazil |
| 7 / 7 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 18 / 18 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID